Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Electronic (PDF)Add to Basket
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
Live Chat Live Help Software for Website

BP to Acquire Cellulosic Biofuels Business from Verenium: An Attempt to Bail Out Its Partner Company - Deal Analysis from GlobalData

GlobalData, Aug 2010, Pages: 5


  Description  
   Table of Contents   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

BP to Acquire Cellulosic Biofuels Business from Verenium: An Attempt to Bail Out Its Partner Company - Deal Analysis from GlobalData

Summary

BP p.l.c., an energy company, entered into an agreement to acquire a cellulosic biofuels business, including facilities, from the Verenium Corporation, a developer of cellulosic ethanol technology, for a purchase consideration of $98.3m. Under the agreement, BP will acquire the facilities located in Jennings, Louisiana, the US, including a pilot plant and a demonstration-scale facility and R&D facilities in San Diego, California, the US, as well as cellulosic biofuels technology, cellulosic enzyme technology and related Intellectual Property (IP). Verenium, which develops enzymes for various industries, is acquiring huge debts. The company’s bioethanol business is not generating much revenue, which is proving detrimental to the company. Therefore, the company has decided to focus on its enzyme business and sell off its biofuel business. In contrast, BP is planning to increase its investments in the renewable energy sector.

Scope

- The information related to the bioethanol asset transaction from Verenium to BP.
- A brief on companies, Verenium and Exergy.
- Comparison of similar deals by oil and gas companies in biofuel sector in the US.
- The rationale behind the acquisition. This includes,
- The future growth path of Verenium.
- The investment plans of BP in altenative energy sector.
- Information related to the assets involved in the deal.

Reasons to buy

The Deal Report attempts to focus on the reason behind the acquisition. It will allow the reader to,
- Understand the reason which made Verenium to sell the biofuel business.
- Understand the motive behind BP buying the biofuel business from Verenium.



Customers who bought this item also bought

Magellan Midstream Partners To Acquire Oil Storage And Pipeline Assets From BP Pipelines: Magellan Midstream Partners is Certainly Strengthening its Position - Deal Analysis from GlobalData

Talisman Energy and Ecopetrol To Acquire BP Exploration Company Colombia: Strategic Development in the Region - Deal Analysis From GlobalData

BP Plc - Strategy, SWOT, and Corporate Finance Report

BP p.l.c. Petrochemicals Capacity and SWOT Analysis

TNK-BP Enters Into An Agreement To Acquire Assets In Vietnam And Venezuela From BP: TNK-BP is Expanding its Business - Deal Analysis From GlobalData

Apache to Acquire Western Desert Business Concessions and East Badr El-din Exploration Concession in Egypt from BP - Deal Analysis from GlobalData

Apache To Acquire Upstream Assets In The Permian Basin From BP - Deal Analysis from GlobalData

Indeck Energy Services Inc. - Overview, Contact Details, Locations, Key executives, Power Plant Information, Business Description and SWOT Analysis

BP To Sell Five Southern African Marketing Businesses To Puma Energy: BP is Divesting its Non Core Assets - Deal Analysis

Apache To Acquire Upstream Assets In Western Canada From BP - Deal Analysis from GlobalData



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds